NCT03991936

Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: Weill Medical College of Cornell University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This purpose of this study is to determine the lowest effective concentration of intralesional triamcinolone acetonide in the treatment of nail psoriasis.

Conditions

• Nail Psoriasis
• Nail Diseases

Interventions

Type	Name	Description
DRUG	Placebos	Normal saline intralesional injection
DRUG	Triamcinolone Acetonide 2.5 mg/mL	2.5 mg/mL intralesional injection
DRUG	Triamcinolone Acetonide 5.0 mg/mL	5.0 mg/mL intralesional injection
DRUG	Triamcinolone Acetonide 7.5 mg/mL	7.5 mg/mL intralesional injection
DRUG	Triamcinolone Acetonide 10 mg/mL	10 mg/mL intralesional injection

Timeline

• Start date: 2020-03-11
• Primary completion: 2023-03-29
• Completion: 2023-03-29
• First posted: 2019-06-19
• Last updated: 2024-03-27
• Results posted: 2024-03-27

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study